Evidence-based laboratory medicine: How well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) Study

Clinical Chemistry

Volumn 58, Issue 1, 2012, Pages 305-306

  Collinson, Paul O ^a   Van Dieijen Visser, Marja P ^b   Pulkki, Kari ^c   Hammerer Lercher, Angelika ^d   Suvisaari, Janne ^e   Ravkilde, Jan ^f   Stavljenic Rukavina, Ana ^g   Baum, Hannsjörg ^h   Laitinen, Päivi ^e,i  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f AALBORG UNIVERSITY HOSPITAL   (Denmark)

^g UNIVERSITY OF ZAGREB   (Croatia)

^h Regionale Kliniken Holding RKH GmbH   (Germany)

ⁱ Central Ostrobothnia Hospital District   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; HYDROXYBUTYRATE DEHYDROGENASE; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME; MYOGLOBIN; TROPONIN T;

ACUTE CORONARY SYNDROME; CLINICAL PROTOCOL; DATA BASE; DATA EXTRACTION; EUROPE; EVIDENCE BASED MEDICINE; GOOD LABORATORY PRACTICE; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEALTH CARE SURVEY; HEART INFARCTION; HOSPITAL LABORATORY; LETTER; PRACTICE GUIDELINE; QUALITY CONTROL; QUESTIONNAIRE; VALIDATION PROCESS;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; CLINICAL LABORATORY TECHNIQUES; EUROPE; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HUMANS; INTERNATIONAL COOPERATION; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; TROPONIN;

EID: 84856075427     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.171439     Document Type: Letter

References (5)

1. Pulkki K, Suvisaari J, Collinson P, Ravkilde J, Stavljenic-Rukavina A, Hammerer-Lercher A, et al. A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe. The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study. Clin Chem Lab Med 2009;47:227-34.
2. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000;21:1502-13.
3. Thygesen K, Alpert JS, White HD, on behalf of the joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 2007;116:2634-53.
4. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 2007;115:e356-75. (Pubitemid 46648624)
5. Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999;45:1104-21. (Pubitemid 29340557)